Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pulmonary Hypertension Associated With Interstitial Lung Disease”

33 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 33 results

Testing effectiveness (Phase 2)Study completedNCT02036970
What this trial is testing

Bardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIAT

Who this might be right for
Pulmonary Arterial HypertensionPulmonary HypertensionInterstitial Lung Disease+9 more
Biogen 166
Testing effectiveness (Phase 2)Ended earlyNCT02138825
What this trial is testing

Efficacy and Safety of Riociguat in Patients With Symptomatic Pulmonary Hypertension (PH) Associated With Idiopathic Interstitial Pneumonias (IIP)

Who this might be right for
Idiopathic Interstitial Pneumonias / Hypertension,Pulmonary
Bayer 147
Testing effectiveness (Phase 2)Looking for participantsNCT07333183
What this trial is testing

Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD

Who this might be right for
Pulmonary HypertensionInterstitial Lung Disease (ILD)Lung Diseases+3 more
Pulmovant, Inc. 20
Post-approval studies (Phase 4)Study completedNCT00403650
What this trial is testing

Inhaled Iloprost for Sarcoidosis-associated Pulmonary Hypertension

Who this might be right for
SarcoidosisPulmonary Arterial Hypertension
University of Cincinnati 20
Testing effectiveness (Phase 2)Study completedNCT03727451
What this trial is testing

A Dose Escalation Study to Assess the Safety and Efficacy of Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Fibrosis or Sarcoidosis

Who this might be right for
Pulmonary HypertensionPulmonary FibrosisSarcoidosis, Pulmonary
Bellerophon 17
Not applicableStudy completedNCT05703802
What this trial is testing

Establishment of an ELISA for the Recognition of Procalcitonin Variants in Patients With Hyperprocalcitonemia.

Who this might be right for
SepsisPre-EclampsiaGranulomatosis With Polyangiitis+4 more
University Hospital Muenster 30
Large-scale testing (Phase 3)Temporarily pausedNCT07181382
What this trial is testing

Efficacy and Safety of Seralutinib in Adult Subjects With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Who this might be right for
Pulmonary Hypertension Associated With Interstitial Lung Disease
GB002, Inc. 480
Testing effectiveness (Phase 2)Ended earlyNCT00703339
What this trial is testing

Effects of Inhaled Treprostinil Sodium for the Treatment of Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary FibrosisPulmonary Hypertension
Lung Biotechnology PBC 1
Not applicableAvailableNCT05356052
What this trial is testing

Expanded Access for Patients With Pulmonary Hypertension Associated With Pulmonary Fibrosis

Who this might be right for
Pulmonary FibrosisPulmonary Hypertension
Bellerophon
Not applicableAvailableNCT06939647
What this trial is testing

An Expanded Access Study to Assess Treprostinil Palmitil Inhalation Powder (TPIP) for Participants With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Who this might be right for
Pulmonary Arterial HypertensionPulmonary Hypertension, Interstitial Lung Disease
Insmed Incorporated
Early research (Phase 1)Study completedNCT02267655
What this trial is testing

3 Part Study to Assess Inhaled Nitric Oxide on Functional Pulmonary Imaging in Subj. Pulmonary Hypertension Associated w/ COPD and IPF

Who this might be right for
Pulmonary HypertensionChronic Obstructive Pulmonary DiseaseIdiopathic Pulmonary Fibrosis
Bellerophon 8
Testing effectiveness (Phase 2)UnknownNCT05747508
What this trial is testing

Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis

Who this might be right for
Pulmonary FibrosisPulmonary Hypertension
Bellerophon 85
Not applicableStudy completedNCT00820729
What this trial is testing

Biomarkers in Pulmonary Hypertension Associated to Interstitial Lung Disease

Who this might be right for
Interstitial Lung DiseasePulmonary HypertensionBiomarkers
University of Aarhus 212
Testing effectiveness (Phase 2)Looking for participantsNCT07175038
What this trial is testing

ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)

Who this might be right for
Pulmonary Arterial Hypertension (PAH)Pulmonary Hypertension, Interstitial Lung Disease
AllRock Bio, Inc. 40
Testing effectiveness (Phase 2)Study completedNCT05176951
What this trial is testing

Evaluate the Safety and Tolerability of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease

Who this might be right for
Pulmonary Hypertension
Insmed Incorporated 39
Testing effectiveness (Phase 2)WithdrawnNCT00323024
What this trial is testing

Dose Determination Safety and Activity Study of Inhaled NX1011 to Treat Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Hypertension
NITROX, LLC 72
Testing effectiveness (Phase 2)Active Not RecruitingNCT06635850
What this trial is testing

Mosliciguat in PH-ILD

Who this might be right for
Pulmonary HypertensionInterstitial Lung DiseaseLung Diseases+3 more
Pulmovant, Inc. 135
Large-scale testing (Phase 3)Not Yet RecruitingNCT07285655
What this trial is testing

Evaluate the Safety and Efficacy L606 in Participants With PH-ILD

Who this might be right for
Pulmonary Hypertension Due to Lung Disease (Disorder)
Liquidia Technologies, Inc. 344
Large-scale testing (Phase 3)Active Not RecruitingNCT04691154
What this trial is testing

Evaluate the Safety and Tolerability of L606 in Subjects With PAH or PH-ILD

Who this might be right for
Pulmonary Arterial HypertensionPulmonary Hypertension Due to Lung Diseases
Liquidia Technologies, Inc. 28
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07441278
What this trial is testing

A Clinical Trial of NS-863 in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Who this might be right for
Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
NS Pharma, Inc. 177
Load More Results